Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn’t
A large study found that people taking GLP-1 weight-loss drugs such as Ozempic and Wegovy became less physically…
The Unexpected Gut Health Risk of Cutting Out Sugar
Researchers found that mice on a sugar-free low-fat diet experienced disrupted gut bacteria, inflammation, insulin resistance, and signs…
GLP-1 Therapies Silence Spontaneous Physical Activity
Summary: Researchers unmasked a critical behavioral paradox in modern weight management, proving that adults utilizing glucagon-like peptide-1 (GLP-1)…
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery
Rani Therapeutics, LLC SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…